More on ATRA

- Summary
- Chart
- Profile
- Historical

Data

- Earnings (+106.1% Growth)
- Ratings (2.7 Score)
- Holders

Upcoming Events

- Earnings (11/12/25 *Est.)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

ATARA Biotherapeutics (NQ:ATRA)
Delayed: 5.17 +0.17 (3.40%)
Prev. Close $5.00  
Open$4.85 
52 Wk High$40.80 
52 Wk Low$12.45 
Day High$5.37 
Day Low$4.70 
P/E N/A  
EPS$0.00 
Volume3,103,563 

Friends, Peers and Foes (?): CNTB (more...)

Mar 4, 2026 04:28 PM Form 4 Atara Biotherapeutics, For: Mar 02 Filed by: Grant-Huerta Yanina
Mar 4, 2026 04:28 PM Form 4 Atara Biotherapeutics, For: Mar 02 Filed by: Nguyen AnhCo
Mar 3, 2026 08:30 AM Form 8-K Atara Biotherapeutics, For: Mar 03
Mar 3, 2026 08:06 AM Atara partner requests FDA meeting on rejected therapy application
Mar 3, 2026 08:05 AM Atara Biotherapeutics Provides Regulatory Update on Tabelecleucel
Mar 2, 2026 06:26 PM Form 144 Atara Biotherapeutics, Filed by: Nguyen AnhCo
Mar 2, 2026 06:25 PM Form 144 Atara Biotherapeutics, Filed by: Grant-Huerta Yanina
Feb 23, 2026 08:29 AM Form 8-K Atara Biotherapeutics, For: Feb 20
Feb 23, 2026 08:00 AM Atara Biotherapeutics extends $9 million payment deadline to 2028
Feb 23, 2026 08:00 AM Atara Biotherapeutics Provides a Business Update
View All Articles

Entities mentioned with ATRA

View All Entities